Efficacy and Safety of Immunoglobulin Associated With Rituximab Versus Rituximab Alone in Childhood-Onset Steroid-dependent Nephrotic Syndrome

NCT03560011 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

SUSPENDED

Status

90

Enrollment

OTHER

Sponsor class

Stopped Decision of Data Safety Monitoring Board

Conditions

Steroid-Dependent Nephrotic Syndrome

Interventions

DRUG: immunoglobulin IV

Sponsor

Assistance Publique - Hôpitaux de Paris